Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Knight Therapeutics Inc. (T.GUD) had Weighted-Average Shares Outstanding (Diluted) of 107.47M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
-18.13M |
|
-- |
|
-- |
|
-- |
|
-0.06M |
|
-- |
|
-19.49M |
|
-12.59M |
|
-18.13M |
|
-18.13M |
|
-18.13M |
|
-9.61M |
|
-0.06M |
|
8.48M |
|
107.47M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
107.47M |
-0.17 |
|
-0.17 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
704.65M |
|
-- |
|
-- |
|
-- |
|
148.03M |
|
556.62M |
|
281.02M |
|
556.62M |
|
101.17M |
|
| Cash Flow Statement Financials | |
26.78M |
|
21.87M |
|
-60.37M |
|
53.42M |
|
43.79M |
|
-9.63M |
|
1.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.20 |
|
-- |
|
-- |
|
0.06 |
|
0.09 |
|
46.11% |
|
-0.11% |
|
-0.11% |
|
-- |
|
-35.25% |
|
-32.79% |
|
27.51M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.44 |
|
0.76 |
|
119.15 |
|
-3.26% |
|
-6.45% |
|
-2.57% |
|
-3.05% |
|
7.38 |
|
0.26 |
|
0.25 |
|